GAP-134 - CAS# 943134-39-2 Catalog No.:M10439-2 5-Carboxyfluorescein

5-Carboxyfluorescein

pre-treatment of the cells with the PI3K inhibitors

1 day after administration

PF-4800567 shows inhibitory activity against CK1ϵ and CK1δ in whole cells

3)27-14-15-12-22(17-6-4-5-7-18(17)23(15)29)28-20-10-11-26-21-13-16(25)8-9-19(20)21

GAP-134 - CAS# 943134-39-2 Catalog No.:M10439-2 5-CarboxyfluoresceinDanegaptide, also known as GAP 134 and ZP1609, is an orally active small molecule gap junction modifier for the treatment of atrial fibrillation. Danegaptide mproves conduction and reduces atrial fibrillation flutter in the canine sterile pericarditis model. Danegaptide prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia reperfusion injury in open chest dogs. Product information CAS Number: 943134 39 2